Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

MSCs help rejuvenate skin by promoting cell growth and reducing inflammation.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

More oxygen isn't always better and can sometimes be worse.

Lack of vitamin D receptor causes hair loss in mice by allowing certain genes to overactivate.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

ROR2 is essential for hair follicle stem cell renewal and maintenance.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.

External factors can cause skin cancer cells that usually don't spread to grow and form tumors in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Newly born mesenchymal cells quickly spread out in response to tissue tension during early development.

CCC1 is essential for pH balance and normal cell function in plants.

Type XVII collagen helps control skin cell growth and may have anti-aging effects.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Foxp1 helps control hair stem cell growth and response to stress during hair growth cycles.

Scientists improved how to grow mouse skin cells in the lab and created a long-lasting cell line, but didn't fully explain its advantages or compare it to normal cells.

Most patients with Lichen planopilaris improved with acitretin, but treatments often didn't work well; preventing infection in skin surgery is important, and bupivacaine might be a better anesthetic.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Autophagy helps control skin inflammation and cancer responses and regulates hair growth by affecting stem cell activity.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.